Equasens Société anonyme (LON: 0R9T)
London
· Delayed Price · Currency is GBP · Price in EUR
36.85
-0.65 (-1.73%)
Jan 23, 2025, 1:41 PM BST
Equasens Société anonyme Revenue
Equasens Société anonyme had revenue of 107.17M EUR in the half year ending December 31, 2023, with 8.07% growth. This brings the company's revenue in the last twelve months to 215.16M, down -1.58% year-over-year. In the year 2023, Equasens Société anonyme had annual revenue of 219.79M with 2.67% growth.
Revenue (ttm)
215.16M EUR
Revenue Growth
-1.58%
P/S Ratio
n/a
Revenue / Employee
169.28K EUR
Employees
1,271
Market Cap
475.42M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 219.79M | 5.71M | 2.67% |
Dec 31, 2022 | 214.08M | 21.01M | 10.88% |
Dec 31, 2021 | 193.07M | 21.32M | 12.41% |
Dec 31, 2020 | 171.75M | 13.19M | 8.31% |
Dec 31, 2019 | 158.57M | 10.09M | 6.79% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |